October, 2021

CRISPR touts new results as fresh questions surround 'off-the-shelf' CAR-T

Bio Pharma Dive

The gene editing company aims to expand its trial and add a second dose to improve effectiveness. However, safety worries have emerged since the FDA ordered CRISPR's rival Allogene to suspend clinical work

Pharma is “big business” that uses excuses to keep prices high

World of DTC Marketing

SUMMARY: Americans spend twice as much per capita on drugs as residents of other wealthy nations, because ours is the only country that lets drugmakers set any price they want for their products.

Sales 224
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

In the News: September 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. FDA Discusses Focus Areas for PDUFA VII During Public Meeting.

Open Source “Wikipedia” for Drug Discovery

Pharma Mirror

By Kambiz Shekdar, Ph.D. Open source drug discovery was proposed in the past in connection with third-world diseases like tuberculosis and malaria, but it is in the context of first-world indications where it is needed most.

A novel neural network to understand symmetry, speed materials research

Scienmag

Understanding structure-property relations is a key goal of materials research, according to Joshua Agar, a faculty member in Lehigh University’s Department of Materials Science and Engineering.

Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor

NY Times

Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all.

Relay's targeted cancer drug could be safer than its competitors. Is it more effective?

Bio Pharma Dive

Initial study results for Relay's experimental treatment offer some support for the biotech's protein motion technology, but raise some questions, too

More Trending

Three Ways Pharma Advertisers Can Benefit from Attention Metrics

Pharma Marketing Network

By: Marc Guldimann, Co-founder and CEO, Adelaide. Targeting and attribution challenges are universal, but pharmaceutical advertisers encounter several unique hurdles with digital advertising.

CPhI Worldwide: 9-11 November 2021 in Milan, Italy

Pharma Mirror

“In a year when literally hundreds of our exhibitors have contributed to overcoming COVID, the greatest healthcare challenge of recent times, we are delighted to be welcoming back the pharma community.

Researchers reach quantum networking milestone in real-world environment

Scienmag

Credit: Carlos Jones/ORNL, U.S. of Energy Journal PRX Quantum DOI 10.1103/PRXQuantum.2.040304 Method of Research Experimental study Subject of Research Not applicable Article Title Reconfigurable Quantum Local Area Network Over Deployed Fiber Article Publication Date 6-Oct-2021.

Merck Says Its Antiviral Pill Is Effective Against Covid

NY Times

The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool against the virus.

Sarepta outlines final push for Duchenne gene therapy

Bio Pharma Dive

The biotech still believes a speedy approval filing for the closely watched treatment is possible, but expects to have to wait for the results of the recently launched Phase 3 trial, CEO Doug Ingram said on a conference call

Moderna executives join Forbes richest at taxpayers expense

World of DTC Marketing

SUMMARY: (Times) The financial windfall at Moderna, the biotech company behind one of the three federally cleared Covid-19 vaccines, has propelled three new names onto Forbes magazine’s list of the 400 wealthiest people in the United States. However, it’s the NIH’s vaccine.

Collins Calls Time for a Change, Steps Down as NIH Director

BioSpace

After serving three presidential administrations, Dr. Francis S. Collins is stepping down as director of the National Institutes of Health at the end of the year

107
107

Samsung Biologics to help Enzolytics advance clinical development of mAbs

BioPharma Reporter

Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing

A cousin of Viagra reduces obesity by stimulating cells to burn fat, study shows

Scienmag

Drugs 83

No return to the status quo: Why now is the time for value-based change

Pharma Phorum

Value-based, person-centred healthcare is the key to system resilience – and now is the time to make it happen. COVID-19 offers a “unique opportunity” to build healthcare systems that are both agile enough to deal with future crises and strong enough to overcome existing challenges.

Gene therapy developer gets chance at a comeback with Pfizer deal

Bio Pharma Dive

Voyager Therapeutics recently scrapped much of its pipeline and replaced top executives. Now, a Pfizer deal on new technology gives investors hope

Pharma losing the battle over drug prices

World of DTC Marketing

Drugs 165

Rejuvenate Bio is Reversing Age-Related Diseases to Increase Healthspan

BioSpace

Unlike most companies addressing the diseases associated with aging, Rejuvenate Bio tackles multiple cardiac, metabolic and renal issues at once

101
101

First subject given COVID-19 vaccine candidate in UK-based Scancell’s COVIDITY trial

Pharma Times

UK-based Scancell Holdings has announced that its first subject has been dosed in its COVIDITY clinical trial in South Africa

Parent Project Muscular Dystrophy’s ground-breaking effort

Scienmag

The ‘patient of the future’ is driving radical innovation in healthcare

Pharma Phorum

Digital data collection, utilisation of real-word data and patient-centric thinking will all contribute to the rapid development of a new healthcare landscape, says Debiopharm Innovation Fund’s Tanja Dowe.

Intergalactic Therapeutics launches with $75M to build a new type of gene therapy

Bio Pharma Dive

Founded by former Biogen executive Michael Ehlers and backed by Apple Tree Partners, Intergalactic aims to create non-viral gene therapies delivered via an advanced form of electroporation

DTC is evolving: 10 things you must do

World of DTC Marketing

SUMMARY : DTC marketing is evolving as patients become more thoughtful about choosing treatment options. The model of “heavy TV followed by a website designed to sell people isn’t going to work anymore.

Alzheimer’s Drug Granted FDA Breakthrough Designation as Space Heats Up

BioSpace

?The decision is based on promising results from the Marguerite RoAD and SCarlet RoAD open-label extension trials, showing a significant reduction in brain amyloid plaque in Alzheimer's patients

Medtronic Expands Two Insulin Pump Recalls, Including One Over Cybersecurity Concerns

XTalks

Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks. The affected remote controller models are MMT-500 and MMT-503.

Oregon State microbiology research furthers understanding of ocean’s role in carbon cycling

Scienmag

CORVALLIS, Ore. Microbiology researchers at Oregon State University have shed new light on the mechanisms of carbon cycling in the ocean, using a novel approach to track which microbes are consuming different types of organic carbon produced by common phytoplankton species.

Twin Health raises $140m for “digital twin” diabetes reversal app

Pharma Phorum

The developer of a toolkit that promises to create a “digital twin” of individuals with chronic metabolic diseases like diabetes to help model the impact of lifestyle changes has secured $140 million in funding to develop the technology.

Merck says antiviral pill effective against COVID-19, lifting hopes for first oral drug

Bio Pharma Dive

The drugmaker, along with partner Ridgeback Biotherapeutics, plan to ask the FDA for emergency authorization "as soon as possible "

Drugs 255

Merck gives taxpayers the middle finger

World of DTC Marketing

SUMMARY: Via Axios – The antiviral pill that showed promising results against severe COVID-19 was initially developed at Emory University with $35 million of taxpayer grants. And while it costs $17.74

First Long-Acting Antibody Cocktail to Prevent COVID-19 Submitted for EUA

BioSpace

AstraZeneca submitted data for an Emergency Use Authorization for AZD7442, a long-acting antibody combination from B-cells donated by patients who recovered from COVID-19

Fungus-derived cancer killing drug by Oxford University shows promise

Pharma Times

A chemotherapy drug, NUC-7738, which is derived from a Himalayan fungus has been found to have 40 times greater potency in killing cancer cells than its original parent compound

Drugs 88

Elastic polymer that is both stiff and tough, resolves long-standing quandary

Scienmag

Polymer science has made possible rubber tires, Teflon and Kevlar, plastic water bottles, nylon jackets among many other ubiquitous features of daily life.

WHO plans pandemic prevention study of COVID’s origins

Pharma Phorum

The World Health Organization has set up a new scientific group to study the origins of COVID-19 in the hope that it will help prevent future pandemics.

Sarepta embarks on late-stage clinical trial of Duchenne gene therapy

Bio Pharma Dive

Initiation of the Phase 3 trial is an important milestone for the biotech after earlier setbacks, as well as for patients with the inherited muscle disease

Will pharma ever get digital?

World of DTC Marketing

SUMMARY : Digital marketing is too damn important to leave to your agency. Pharma needs to develop digital marketing expertise in-house and have marketing people integrated within each brand team. There it was again.